COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION IN ITALY
Author(s)
Mantovani LG1, Cortesi PA1, Senni M2, Deschaseaux C3, Haroun R3, Pitotti C4
1University of Milano-Bicocca, Monza, Italy, 2ASST Papa Giovanni XXIII, Bergamo, Italy, 3Novartis Pharma AG, Basel, Switzerland, 4Novartis Farma, Origgio, Italy
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PCV80
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Cardiovascular Disorders